Acquired Digital Fibrokeratoma (Acral Fibrokeratoma)
Acquired Digital Fibrokeratoma
Also known as an Acral Fibrokeratoma
Are You Confident of the Diagnosis?
What you should be alert for in the history
Patients often present complaining of an asymptomatic growth on the hand or foot.
Characteristic findings on physical examination
These lesions are characterized by a flesh-colored hyperkeratotic protuberence surrounded by a collarette of surrounding skin. Lesions usually measure 4-8 mm in diameter, but lesions up to 3 cm have been reported.
Expected results of diagnostic studies
When submitted for histologic examination, sections show a well-defined papule with a narrow stalk (
Acquired digital fibrokeratoma (X10). Note the narrow stalk of the papule.
Acquired digital fibrokeratoma (X40). Vertically oriented collagen at the center of the lesion.
Verruca vulgaris may mimic an acquired digital fibrokeratoma. Verrucae are caused by human papilloma virus and are spread by contact. They are distinguished from acquired digital fibrokeratomas by the lack of a collarette and a rough hyperkeratotic surface. Multiple verruca are often present, whereas acquired digital fibrokeratoma are solitary.
Pyogenic granulomas are rapidly growing vascular tumors that often occur on the hands. These lesions have a collarette surrounding the base, but have a friable core that bleeds easily.
Supernumerary digits are similar in appearance to acquired digital fibrokeratomas, but are present in birth. They represent a duplication of a digit with a tissue core of bone, cartilage, and/or neural tissue.
Periungual fibroma (Koenen’s Tumor) is associated with Tuberous Sclerosis. These lesions are hyperkeratotic growths that occur around the nails and may cause nail dystrophy. They begin to develop in late childhood and increase in number with age. Periungual fibromas may also appear to have a collarette, but this usually represents the distorted nail fold. The location, multiple lesions, and lack of a true collarette differentiate these lesions from an acquired digital fibrokeratoma.
Squamous cell carcinoma can also mimic an acquired digital fibrokeratoma. These lesions often occur in middle-age and older individuals with a significant amount of sun exposure. Squamous cell carcinoma does not have a collarette, but may have a hyperkeratotic, rough surface. Bleeding and ulceration may occur. Often these lesions have a history of slow continued growth and are not confined to a small, narrow base.
Acquired periungual fibrokeratomas are rare tumors that form on the nail fold that are histologically identical to an acquired digital fibrokeratoma.
Who is at Risk for Developing this Disease?
This benign lesion may occur at any age, but most commonly affects middle-age patients. Both sexes and all ethnic groups may be affected. The development of acquired digital fibrokeratomas is spontaneous and without any association with other medical conditions.
What is the Cause of the Disease?
While no known cause for the formation of this lesion has been shown, it may represent an abnormal healing reponse to mild trauma.
Systemic Implications and Complications
There are no associations with any other disease states.
Carbon dioxide laser ablation
Electrodessication and curettage
Optimal Therapeutic Approach for this Disease
Simple surgical excision is the best method for removing an acquired digital fibrokeratoma. Simple saucerization with application of ointment such as vaseline and a bandage will allow healing of the site within 1 to 2 weeks. Other destructive methods including laser, cryosurgery, and electrodessication can also be employed if surgical excision cannot be employed. These methods also heal in 1 to 2 weeks, but have a higher risk of developing a cosmetically unappealing scar.
Acquired digital fibrokeratomas uncommonly recur weeks to months after surgical excision or destruction. If lesions recurs, excision or destruction should be repeated.
Unusual Clinical Scenarios to Consider in Patient Management
Acquired digital fibrokeratomas are usually solitary lesions. If patient have multiple lesions, they may represent Koenen tumors and the patient should be assessed for tuberous sclerosis.
What is the Evidence?
Kakurai, M, Yamada, T, Kiyosawa, T, Ohtsuki, M, Nakagawa, H. "Giant acquired digital fibrokeratoma". J Am Acad Dermatol. vol. 48. 2003. pp. S67-8.(This article provides a brief synopsis of acquired digital fibrokeratomas and presents a case report of a very large lesion. Chronic trauma may have lead to the development of this large lesion.)
Carlson, RM, Lloyd, KM, Campbell, TE. "Acquired periungual fibrokeratoma: a case report". Cutis. vol. 80. 2007. pp. 137-40.(This reference discusses acquired periungual fibrokeratomas and their relationship to acquired digital fibrokeratomas. This article discusses the differential diagnosis for periungual lesions including Koenen tumors.)
Baykal, C, Buyukbabni, N, Yazganoglu, KD, Saglik, E. "Acquired digital fibrokeratoma". Cutis. vol. 79. 2007. pp. 129-32.(This article discusses the clinical findings and differential diagnosis of acquired digital fibrokeratomas. This provides a simple, easy to read review on the subject.)
Vinson, RP, Angeloni, VL. "Acquired digital fibrokeratoma". Am Fam Physician. vol. 52. 1995. pp. 1365-7.(This article presents acquired digital fibrokeratomas to the primary care physician. It provides a comprehensive review of the clinical findings, a discussion of the important differential diagnoses, and appropriate management of this lesion.)
Copyright © 2017, 2012 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Moving Targets: Off-Label Prescribing of Targeted Therapies
- New Algorithm Improves Outcome Prediction for Diffuse Large B-Cell Lymphoma
- 2-Year TKI Consolidation Allowed for TKI Cessation in Select Patients With CML
- Trial Identifies Marker for Response to Immunotherapy in Esophageal Cancer
- Immunotherapy Combo in Head and Neck Cancer Shows Activity in Phase 2 Trial
- Nutraceuticals/Supplements and Cancer Prevention: All Hype?
- Plastics and Cancer
- Encorafenib Plus Binimetinib Offers a New Option for MEK+BRAF Inhibition
- Reclassification of Variants of Uncertain Significance: A Q&A With Theodora Ross MD, PhD
- Using ctDNA to Predict Cancer Recurrence and Guide Therapy Selection
- Study Adds More Evidence to Support Active Surveillance as the Standard of Care for Certain Desmoid Tumors
- Palliative Care and Survivorship
- Dosing Schedule May Be Key to Optimal Administration of Milademetan for Sarcoma Subtype
- Phase 2 Trial of Abemaciclib in Dedifferentiated Liposarcoma Meets Primary End Point
- Mouse-Dog-Human Preclinical Cancer Model for Osteosarcoma Proposed